|
Oncology drug development is costly and risky. Just one drug can take almost a decade with a USD 1 billion price tag. Yet approval rates can drop as low as 5 percent. If you wait until registration to think about what stakeholders expect, you may be starting over. Problem is, each of your stakeholders define value differently. Quintiles helps you understand their expectations so you can integrate commercial insights into the development process from the very beginning, identifying the most critical value endpoints to design more efficient clinical trials.
In The New Health, accelerate success.
Watch video: Evolving the Oncology Paradigm
 |
|
|
|
** Last chance to register for this exclusive live event **
Date: Tuesday 20 March 2012
Time: 3pm GMT
Length: 1 hour (incl. Q&A session)
Join us for presentations from some of the leading experts in the fields of monitoring and compliance and pharmaceutical water and cleanroom facility standards:
Regulation:
Breaking news on the revision of ISO 14644 and 14698
Water systems:
How to meet EP TOC requirements with an on-line TOC analyzer designed for PAT and Real-Time-Release
Cleanrooms:
New paperless methods solve problems for monitoring airborne particles
Register now >>
|
|
|
|
|
|
|
|
|
|
|
|
Merck is to create the California Institute for Biomedical Research (Calibr), an independent, not-for-profit organization (501c3) established to accelerate the translation of basic biomedical research into innovative, new medicines to treat disease.
Calibr will be led by Peter G. Schultz, Ph.D., a world-renowned chemist and biotechnology entrepreneur. The Institute will offer academic scientists, around the world, a streamlined, efficient and flexible path for translating their biomedical research into novel medicines.
Read full story >>
|
|
 |
|
|
|
|
|
|
|
|
|
Conferences, events & exhibitions:
PITTCON 2012 - Exhibition Round-up
Orlando, FL, USA
European Pharmaceutical Review were in attendance at Pittcon 2012. With nearly 900 exhibitors in attendance this year, it was another great event. Read exclusive interviews with some of the key figures at this year's event...
Process Validation for Drugs and Biologics
26 - 27 March 2012, Dublin, Ireland
2nd Annual Drug Discovery Global Summit
27 - 28 March 2012, London, UK
Select Biosciences: AMT/LoaCEC/SCAE/AB&B
28 - 29 March 2012, Edinburgh, Scotland
IPhEB 2012 2nd St. Petersburg International Pharmacy Engineering and Biotechnology Forum
3 - 5 April 2012, St. Petersburg, Russia
Development and Validation of Bioanalytical Assays for Biologics: Quantification (PK) and Immunogenicity Assays
12 - 13 April 2012, Dublin, Ireland
Analytical Method Validation for Biologics, Biopharmaceuticals and Other Therapeutic Products
23 - 24 April, Berlin, Germany
Pharma QbD Forum
24 - 25 April 2012, Berlin, Germany
LogiPharma Europe
24 - 26 April 2012, Geneva, Switzerland
QA/QC Strategy for Biopharmaceuticals and Biologics
25 - 27 April 2012, Berlin, Germany
Austropharm
26 - 28 April 2012, Vienna, Austria
RNAi & Single Cell Biology-2012 Summit
1 - 2 May 2012, Waltham, USA
|
|
|
